Spots Global Cancer Trial Database for Radiotherapy-Associated Atrial Fibrillation

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Radiotherapy-Associated Atrial Fibrillation

Official Title: Radiotherapy-associated Atrial Fibrillation: Onset Time and Frequency

Study ID: NCT05927246

Conditions

Atrial Fibrillation New Onset

Interventions

ECG

Study Description

Brief Summary: Radiotherapy associated Atrial Fibrillation (RADAF) is an observational study to evaluate onset time and frequency of atrial fibrillation in patients with thoracic malignancies and breast cancer. Each patient will have 12 lead ECG prior, and daily during radiotherapy.

Detailed Description: Collected data will be truly anonymised and individuals will no longer identifiable, and than evaluated for occurrence of atrial fibrillation. Inclusing Criteria: 1. Patients with radiotherapy for thoracic malignancy or breast cancer 2. Between 18-99 years-old Exclusion Criteria: 1. Patients with history of radiotherapy 2. Patients with history of atrial fibrillation 3. Patients with pacemaker implantation